Group One Trading’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.1K Sell
13,900
-175,400
-93% -$555K ﹤0.01% 5471
2025
Q4
$700K Sell
189,300
-66,600
-26% -$215K ﹤0.01% 3204
2025
Q3
$678K Buy
255,900
+85,200
+50% +$165K ﹤0.01% 3399
2025
Q2
$168K Sell
170,700
-29,900
-15% -$29.9K ﹤0.01% 4507
2025
Q1
$289K Sell
200,600
-189,600
-49% -$349K ﹤0.01% 3643
2024
Q4
$858K Buy
390,200
+140,100
+56% +$327K ﹤0.01% 2716
2024
Q3
$413K Buy
250,100
+94,800
+61% +$191K ﹤0.01% 3008
2024
Q2
$345K Buy
155,300
+39,200
+34% +$92.2K ﹤0.01% 2907
2024
Q1
$311K Buy
116,100
+33,100
+40% +$80.4K ﹤0.01% 3183
2023
Q4
$248K Sell
83,000
-72,300
-47% -$93.8K ﹤0.01% 3668
2023
Q3
$152K Sell
155,300
-217,200
-58% -$314K ﹤0.01% 4052
2023
Q2
$518K Buy
372,500
+54,900
+17% +$76.7K ﹤0.01% 2980
2023
Q1
$505K Sell
317,600
-2,600
-0.8% -$13.4K ﹤0.01% 2775
2022
Q4
$1.99M Buy
320,200
+281,600
+730% +$2.01M ﹤0.01% 1817
2022
Q3
$259K Buy
38,600
+5,100
+15% +$35K ﹤0.01% 3898
2022
Q2
$213K Buy
33,500
+6,800
+25% +$38.6K ﹤0.01% 4250
2022
Q1
$124K Sell
26,700
-46,300
-63% -$199K ﹤0.01% 5286
2021
Q4
$365K Buy
73,000
+56,500
+342% +$452K ﹤0.01% 4470
2021
Q3
$199K Buy
16,500
+6,000
+57% +$87.4K ﹤0.01% 5175
2021
Q2
$222K Buy
10,500
+3,300
+46% +$79.5K ﹤0.01% 5137
2021
Q1
$202K Buy
7,200
+1,500
+26% +$44.3K ﹤0.01% 5019
2020
Q4
$148K Sell
5,700
-5,500
-49% -$165K ﹤0.01% 4287
2020
Q3
$416K Sell
11,200
-8,200
-42% -$325K ﹤0.01% 3005
2020
Q2
$995K Buy
19,400
+4,600
+31% +$192K ﹤0.01% 2027
2020
Q1
$467K Buy
14,800
+3,700
+33% +$195K ﹤0.01% 2097
2019
Q4
$662K Buy
11,100
+4,700
+73% +$211K ﹤0.01% 2211
2019
Q3
$235K Sell
6,400
-6,900
-52% -$273K ﹤0.01% 2966
2019
Q2
$619K Sell
13,300
-23,100
-63% -$1.08M 0.01% 1947
2019
Q1
$1.46M Sell
36,400
-75,300
-67% -$3.38M 0.02% 1143
2018
Q4
$5.14M Sell
111,700
-23,900
-18% -$1.15M 0.04% 498
2018
Q3
$6.02M Sell
135,600
-24,200
-15% -$1.11M 0.05% 485
2018
Q2
$6.26M Buy
159,800
+121,900
+322% +$6.16M 0.05% 433
2018
Q1
$2.74M Buy
37,900
+29,600
+357% +$2.17M 0.03% 791
2017
Q4
$546K Sell
8,300
-43,800
-84% -$2.36M ﹤0.01% 2182
2017
Q3
$2.61M Sell
52,100
-91,900
-64% -$4.43M 0.02% 882
2017
Q2
$6.66M Sell
144,000
-252,400
-64% -$9.28M 0.07% 346
2017
Q1
$14M Buy
+396,400
New +$9.08M 0.16% 122
2016
Q4
Sell
-200
Closed -$3K 4514
2016
Q3
$3K Buy
200
+100
+100% +$1.13K ﹤0.01% 4298
2016
Q2
$1K Sell
100
-5,000
-98% -$82.9K ﹤0.01% 4503
2016
Q1
$86K Buy
5,100
+3,700
+264% +$59.5K ﹤0.01% 2926
2015
Q4
$31K Sell
1,400
-35,200
-96% -$888K ﹤0.01% 3692
2015
Q3
$863K Buy
36,600
+12,600
+53% +$791K 0.01% 1357
2015
Q2
$1.96M Sell
24,000
-100
-0.4% -$9.79K 0.03% 766
2015
Q1
$2.23M Buy
24,100
+10,800
+81% +$697K 0.04% 582
2014
Q4
$538K Buy
+13,300
New +$407K 0.01% 1488

Other funds holding ESPR